203 related articles for article (PubMed ID: 27939215)
1. The functional activities of complement factor H are impaired in patients with ANCA-positive vasculitis.
Chen SF; Wang FM; Li ZY; Yu F; Chen M; Zhao MH
Clin Immunol; 2017 Feb; 175():41-50. PubMed ID: 27939215
[TBL] [Abstract][Full Text] [Related]
2. Complement Factor H Inhibits Anti-Neutrophil Cytoplasmic Autoantibody-Induced Neutrophil Activation by Interacting With Neutrophils.
Chen SF; Wang FM; Li ZY; Yu F; Chen M; Zhao MH
Front Immunol; 2018; 9():559. PubMed ID: 29616045
[TBL] [Abstract][Full Text] [Related]
3. Complement in ANCA-associated glomerulonephritis.
Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis.
Sethi S; Zand L; De Vriese AS; Specks U; Vrana JA; Kanwar S; Kurtin P; Theis JD; Angioi A; Cornell L; Fervenza FC
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i139-i145. PubMed ID: 28391334
[TBL] [Abstract][Full Text] [Related]
5. Complement in ANCA-associated vasculitis.
Charles Jennette J; Xiao H; Hu P
Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040
[TBL] [Abstract][Full Text] [Related]
6. Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside.
Brilland B; Garnier AS; Chevailler A; Jeannin P; Subra JF; Augusto JF
Autoimmun Rev; 2020 Jan; 19(1):102424. PubMed ID: 31734405
[TBL] [Abstract][Full Text] [Related]
7. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
[TBL] [Abstract][Full Text] [Related]
8. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil extracellular traps can activate alternative complement pathways.
Wang H; Wang C; Zhao MH; Chen M
Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
[TBL] [Abstract][Full Text] [Related]
10. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
11. The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.
Trivioli G; Vaglio A
Clin Exp Immunol; 2020 Dec; 202(3):403-406. PubMed ID: 32946609
[TBL] [Abstract][Full Text] [Related]
12. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
[TBL] [Abstract][Full Text] [Related]
13. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
Shah S; Havill J; Rahman MH; Geetha D
Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
[TBL] [Abstract][Full Text] [Related]
14. Complement system activation in ANCA vasculitis: A translational success story?
Kallenberg CG; Heeringa P
Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
[TBL] [Abstract][Full Text] [Related]
15. Complement in antineutrophil cytoplasmic antibody-associated vasculitis.
Yuan J; Chen M; Zhao MH
Clin Exp Nephrol; 2013 Oct; 17(5):642-645. PubMed ID: 23180036
[TBL] [Abstract][Full Text] [Related]
16. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
[TBL] [Abstract][Full Text] [Related]
17. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis.
Xing GQ; Chen M; Liu G; Heeringa P; Zhang JJ; Zheng X; E J; Kallenberg CG; Zhao MH
J Clin Immunol; 2009 May; 29(3):282-91. PubMed ID: 19067130
[TBL] [Abstract][Full Text] [Related]
18. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase influences the complement regulatory activity of complement factor H.
Chen SF; Wang FM; Li ZY; Yu F; Chen M; Zhao MH
Rheumatology (Oxford); 2018 Dec; 57(12):2213-2224. PubMed ID: 29471467
[TBL] [Abstract][Full Text] [Related]
20. Complement in ANCA-associated vasculitis: mechanisms and implications for management.
Chen M; Jayne DRW; Zhao MH
Nat Rev Nephrol; 2017 Jun; 13(6):359-367. PubMed ID: 28316335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
